Table 4. Serious Adverse Events in the Modified Intention-to-Treat Population.

Adverse event	No. (%) of patients
	Intervention (n = 121)	Control (n = 117)
Patients with at least 1 serious adverse event at 30 d	19 (15.7)	19 (16.2)
Intracranial hemorrhage	0	3 (2.6)
Extracranial hemorrhage	1 (0.8)	1 (0.9)
Stroke progression	2 (1.7)	2 (1.7)
New ischemic stroke	2 (1.7)	2 (1.7)
Allergic reaction	0	0
Pneumonia	1 (0.8)	3 (2.6)
Other infection	1 (0.8)	2 (1.7)
Other serious adverse event	12 (9.9)	9 (7.7)